According to cognitive market research, the global levothyroxine market size was USD 3951.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 3.50% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 1580.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 1.7% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 1185.36 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 908.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 197.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.9% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 79.02 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.2% from 2024 to 2031.
The injectables category is the fastest growing segment of the levothyroxine industry
